Collection
MeSH Terms
caplacizumab, guidelines, rituximab, treatment, TTP
Keywords
caplacizumab, guidelines, rituximab, treatment, TTP
Record Publish Year
2020
Publication Date
01-Oct-20
Methods Applied
The panel used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, including evidence-to-decision frameworks, to appraise evidence and formulate recommendations.
Guideline Contact
X. Long Zheng, Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 5016 Delp, 3901 Rainbow Blvd, Kansas City 66160, KS, USA.Emails: [email protected] or [email protected] OR Flora Peyvandi, Fondazione IRCCS Ca’ Granda Ospedale Maggiore, Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy. Email: [email protected]
Publication Scope
treatment
Countries of Application
International
United States
Guideline Publication Status
Published
Languages
English
Authors
ISTH
Willingness to Collaborate
Yes
Publication Year
2020